Danaher Co. (NYSE:DHR - Free Report) - Investment analysts at Zacks Research reduced their Q2 2025 earnings per share estimates for shares of Danaher in a report released on Thursday, November 21st. Zacks Research analyst R. Department now expects that the conglomerate will post earnings per share of $1.90 for the quarter, down from their prior estimate of $1.91. The consensus estimate for Danaher's current full-year earnings is $7.50 per share. Zacks Research also issued estimates for Danaher's Q4 2025 earnings at $2.33 EPS and FY2025 earnings at $8.22 EPS.
DHR has been the topic of several other reports. Raymond James lowered their price objective on Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI boosted their target price on Danaher from $275.00 to $278.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 1st. Robert W. Baird decreased their target price on Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 23rd. KeyCorp boosted their target price on Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 23rd. Finally, Royal Bank of Canada decreased their target price on Danaher from $333.00 to $311.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and a consensus price target of $287.16.
Read Our Latest Research Report on Danaher
Danaher Price Performance
Shares of Danaher stock traded up $1.63 during trading hours on Monday, hitting $237.47. The company's stock had a trading volume of 770,649 shares, compared to its average volume of 2,752,562. The business has a 50 day moving average price of $258.15 and a two-hundred day moving average price of $260.03. Danaher has a 12-month low of $215.68 and a 12-month high of $281.70. The company has a market cap of $171.52 billion, a PE ratio of 45.01, a PEG ratio of 4.34 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.
Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the previous year, the business earned $2.02 earnings per share. Danaher's quarterly revenue was up 3.1% compared to the same quarter last year.
Hedge Funds Weigh In On Danaher
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. nVerses Capital LLC acquired a new stake in Danaher in the second quarter worth about $25,000. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher in the second quarter worth about $25,000. Teachers Insurance & Annuity Association of America acquired a new stake in Danaher in the third quarter worth about $39,000. MidAtlantic Capital Management Inc. acquired a new stake in Danaher in the third quarter worth about $40,000. Finally, FSA Wealth Management LLC purchased a new position in shares of Danaher in the third quarter worth about $50,000. Institutional investors own 79.05% of the company's stock.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher's payout ratio is 20.61%.
Danaher Company Profile
(
Get Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
